Anterior Temporal Resection



Anterior Temporal Resection


Kenneth Vives

Gabriel Lee

Werner Doyle

Dennis D. Spencer



Introduction

Temporal lobectomy is the most common surgical procedure performed for medically refractory symptomatic epilepsy. This operation has evolved with our understanding of the pathophysiology of medial temporal epileptogenesis. The neurosurgical approaches presented in this chapter reflect this evolution and, undoubtedly, will continue to change as we refine our knowledge of the responsible epileptogenic substrates in the temporal lobe and other lobar regions. In fact, defining the symptomatic epilepsies by substrate adds the needed specific pathologic diagnosis to the traditional lobar localization classification to further characterize the various diseases that are expressed as temporal lobe epilepsy (TLE).73 Temporal lobectomy continues to play an important role not only in the treatment of epilepsy, but also as a bridge between laboratory and clinical research because the resected tissue is assumed to be epileptogenic and a variety of neurobiologic tools can be used to examine this hypothesis. The modern neurosurgical rationale for the more selective medial temporal resections depends on our contemporary knowledge of temporal lobe function and the pathophysiology of the epileptogenic substrates. This has continued to evolve over time as our knowledge about patient selection and outcomes has expanded and accumulated.


Historical Perspective

Bouchet and Cazauvieilh, in 1825, described grossly visible and palpable abnormalities of hippocampal autopsy specimens obtained from nine patients with “alienation epilepsy.”7 This was the first evidence linking the most common form of partial epilepsy to a pathologic substrate. In another autopsy study, Sommer, in 1880, described gliosis and pyramidal cell loss within the hippocampus of epileptic patients and hypothesized that this finding was responsible for their epilepsy.71 In 1872, Hughlings Jackson suggested that hyperexcitable brain adjacent to temporal lobe lesions was responsible for epilepsy, and in 1888 he pointed out the association of the “dreamy state” and the classic auras of taste, smell, and epigastric sensations with temporal lobe lesions.30 Therefore, well over 100 years ago, a variety of temporal lobe epileptogenic substrates were recognized.

Surgical resection provided the link between medial temporal pathology and seizures by permitting the correlation of seizure control and electrophysiologic evidence of epileptogenicity with the resected tissue’s histopathology. The first operations were pioneered by Horsley18 in 1886, who performed surgery for epilepsy by excising visible cortical scars. Bailey and Gibbs, in 1951, popularized the resection of the temporal lobe using electrographic data, limiting their resection to the lateral temporal cortex.5 Penfield20 also adopted intraoperative electrocorticography (ECoG) to determine the extent of his temporal lobectomy, but, with Baldwin, he noted an increase in successful outcome with more complete resection of the medial structures (amygdala and anterior hippocampus).60


Early Role of Pathology

Surgical experience continued to verify the significance of the medial abnormalities. Earle et al.,12 in 1953, described diffuse atrophic changes in the inferior medial portion of the temporal lobe in the majority of their patients with epilepsy who underwent temporal lobectomy. Margerison and Corsellis43 found hippocampal sclerosis (neuron loss and gliosis) in patients diagnosed with TLE. Morris, in 1956, described intraoperative abnormal electrographic discharges originating from the amygdala and anterior hippocampus and pointed out that pathologic changes were most noticeable in these structures.48 He proposed that the “standard temporal lobectomy” should include 6.5 cm of the lateral cortex, the uncus, the amygdala, and 2 to 4 cm of the anterior hippocampus. This was similar to Walker’s description of the standard temporal lobectomy.97 Falconer then described detailed pathology in the en bloc temporal lobe resections he performed. The atrophy and gliosis he found included and extended beyond the hippocampus, leading him to call the abnormality mesial temporal sclerosis (MTS).15 He noted that patients exhibited a better prognosis if either MTS or a lesion was discovered within the specimen.16,17 Falconer also directed his resection to the lateral temporal neocortex, but the emphasis on medial pathology served to help model most technical modifications that followed.


Impact of Early Electrophysiology Studies

Stereotactic depth recordings, introduced by Bancaud and Talairach,6,88 further altered patient selection. This technique of using acute interictal recordings with depth electrodes provided better intracranial electrophysiologic localization of some partial epilepsies. Crandall also used depth electrodes, but extended the use to chronic recordings of both medial and lateral temporal lobe during seizure events. He also adopted a standardized en bloc resection, which preserved the tissue anatomically, and this was, therefore, well suited for the correlation of ictal electrophysiology with tissue histopathology.9,38 These intracranial studies demonstrated the frequent hippocampal origin of ictal events in TLE, stimulating further surgical interest in medial resection and setting the stage for more selective surgical intervention and more sophisticated tissue studies.75,101


Impact of Neuroimaging

During the decade between 1975 and 1985, computerized tomography (CT) revolutionized neurology’s and neurosurgery’s diagnostic acumen, particularly regarding intracranial hemorrhage, stroke, and some brain tumors. The impact on the surgery of medically refractory epilepsy was limited, but a great
deal of progress was made by coupling video electroencephalographic (EEG) monitoring and intracranial electrode technology. Positron emission tomography (PET) began to confirm unilateral temporal lobe metabolic dysfunction in a majority of patients who were concordantly localized to the same medial temporal lobe.14 In the late 1980s, magnetic resonance imaging (MRI) confirmed that the neuronal loss and gliosis that had been demonstrated pathologically for decades could be visualized as hippocampal atrophy and signal change. This stimulated a number of clinical investigations that correlated these MRI changes with both quantitative hippocampal cell counts and qualitative visualization and surgical outcome. Because these were retrospective studies, it is not surprising that there is a strong correlation of hippocampal pathology and MRI hippocampal atrophy discovered in patients coming to partial temporal lobe resection. In most studies, an imaging abnormality was a major criterion for selection of surgical candidates. On the other hand, even in series in which both MRI and invasive monitoring were used to select patients with presumed TLE, a high incidence of hippocampal neuronal loss and gliosis was identified in the resected tissue and was highly correlated with preoperative MRI quantitative atrophy and hippocampal signal change.35,36,81

A meta-analysis of the literature was performed to determine whether any one imaging method was more sensitive to the detection of TLE and how these methods correlated with each other.80 The techniques available for analysis included MRI, single-photon emission computed tomography (SPECT), and PET. Both MRI and PET were highly intercorrelative and quite sensitive and specific to mesial temporal sclerosis the most common substrate of medial temporal lobe epilepsy (MTLE), but they did not delineate other forms of pathology that might be more subtle and more regional, such as cortical dysgenesis. There is evidence that the extent of resection of areas identified as hypometabolic by PET is related to short-term outcome.94 Thus, imaging, invasive electrophysiology, and light microscopic pathologic studies directed the surgeon’s attention to the medial temporal structures as the primary generator or amplifier in TLE. What has become increasingly clear is that the medial temporal structures participate in a much larger, complex network. The individual variations in both the location and extent of damage of this network lead to the clinical phenomena that we associate with temporal lobe epilepsy. Magnetic resonance spectroscopic imaging has also corroborated evidence based on anatomic MRI that frequently there are bilateral medial temporal abnormalities.58 These abnormalities may actually improve following resection of the lobe responsible for seizure generation.92 It is likely that variations in both of these network-related findings contribute to variations in outcomes as well.


Frequency of Use

Temporal lobe resection in some form continues to be the most commonly performed operation for the medically intractable symptomatic epilepsies. Almost all temporal lobectomies performed before the late 1970s involved a generous lateral temporal neocortical resection, which was either standard or determined by intraoperative ECOG spikes and limited by essential cortex such as language and visual fields. The volume of medial hippocampus, parahippocampus, and amygdala removed was extremely variable and surgeon dependent.

In the late 1970s, based on invasive electrophysiology and pathology, Spencer modified the standard resection for those patients with medial temporal ictal onset, such that all of the medial structures (amygdala, hippocampus, and parahippocampus) were removed via a limited temporal pole resection.75 At the same time, Wieser and Yasargil independently devised the more restricted amygdalohippocampectomy for presumptive medial basal epilepsy with or without an associated amygdalohippocampal mass (usually tumor).100 Although some centers still perform generous lateral resections often based on ECOG, modifications of these more selective medial approaches have been used increasingly over the last decade. The increased use of selective medial resection has been based on the aforementioned convergence of medial electropathophysiology and on additional literature demonstrating more failures of temporal lobe resection when the medial structures are incompletely resected.51,56,63

Recently, a number of centers have looked at the seizure and neuropsychological outcomes of patients that have undergone transsylvian selective amygdalohippocampectomy.57 These results seem to indicate that seizure control is equivalent to that with resections that involve limited resection of the lateral structures.57 The neuropsychological results show either equivalence41 or some trends toward decreased morbidity for functions involving the temporal lobe but increased morbidity for frontal lobe functions, especially when associated with subarachnoid hemorrhage from the sylvian dissection.25


Indications


Principal Candidates

The following discussion is concerned with patients undergoing evaluation for surgical candidacy for treatment of intractable epilepsy. Typically, patients with new-onset seizures and significant MRI findings are treated with paradigms that address their underlying pathology first but may be considered for epilepsy surgery should their epilepsy prove to be intractable despite optimal treatment of their underlying pathology.


Patients With Pathogenesis Acquired Younger Than the Age of 4 to 5 Years

Three groups of MRI-analyzed substrates are commonly recognized as epileptogenic and when found in the temporal lobe are presumed to be responsible for the ictal events and the typical behavior of TLE. The first is classical MTLE associated with the pathology of MTS (neuronal cell loss, gliosis, and synaptic reorganization). The other imaged substrates are responsible for lesion-related TLE (LRTLE) and are not restricted to the temporal lobe but may interact uniquely with this portion of the limbic system and require special attention, particularly when they are situated medially. These are primarily vascular cavernous angiomas (CAs), arteriovenous malformations (AVMs), focal developmental abnormalities (DAs), and low-grade neoplasms. The last group, cryptogenic TLE (CTLE), has no imaged lesion or atrophy, and the temporal lobe is identified as the presumed epileptogenic source based primarily on electrophysiology.

MTLE represents 60% to 70% of all localization-related epilepsies and constitutes a syndrome because it has been defined by a common etiology (early injury, particularly febrile seizure at age <4 years), diagnostic evaluation, unilateral ictal EEG and MRI hippocampal atrophy, resistance to medical therapy, and responsiveness to selective resection. The pathogenesis of this syndrome represents a special substrate (MTS), even if the etiology and maintenance of epileptogenicity are not fully understood.

The patients with LRTLE do not have a significant history of early injury, are older when their seizures begin, most frequently have unilateral temporal scalp EEG ictal onset, and, with the exception of some DAs, respond well to resection of the mass and a surrounding margin of tissue.77 It is not clear whether any of the medial temporal lobe structures other than
the immediate surround need to be included in the resection for seizure control. The resected hippocampi of this group generally have the characteristics of relatively normal tissue, with only some neuronal loss and no reorganization.33 A variable percentage of hippocampi associated with lesions may demonstrate atrophy on MRI. This does not necessarily indicate that the atrophic hippocampus is nonfunctional and epileptogenic and should be removed.21 Although this dual pathology has been increasingly characterized by hippocampal atrophy with neocortical DAs (mostly neuronal dysgenesis), the concurrence of a mass and hippocampal atrophy has stirred a debate regarding whether the hippocampus has been only passively injured or is epileptogenic and needs to be removed for best seizure control.37 There are insufficient data to answer this question, but it is particularly relevant when dominant, temporal lobe–specific, short-term memory is normal or only mildly impaired and a medial dominant mass has been targeted for resection. Is the atrophic hippocampus or its more normal adjacent parahippocampus capable of normal function, and is there a risk of cognitive deficits if it is included in the resection?66 The LRTLE group shares this feature of a usually preserved hippocampus with patients in the CTLE group. Patients with CTLE have presumptive electrophysiologic localization but do not have the consistent history of developmental injury or medial temporal lobe atrophy visualized on MRI.


Patients With Pathogenesis Acquired Older Than the Age of 4 or 5 Years

Trauma and infection after the age of 4 or 5 years may cause isolated injury and consequent excitability in one temporal lobe, but frequently there is more diffuse neocortical involvement requiring invasive electrophysiology for localization.

Thus, patients who have medically intractable complex partial seizures with regional temporal lobe scalp EEG localization may be candidates for some form of temporal lobe resection. The form this resection takes, however, varies considerably with a given substrate. Patients with CTLE or TLE acquired after age 4 or 5 years should be evaluated for resection based on invasive recordings, and such resection should exclude the reorganized essential brain, such as those areas governing language and verbal memory.


Evaluation Criteria

Selecting patients with TLE for the appropriate operation begins by first using MRI to classify them into the three anatomic substrate categories noted earlier: (a) hippocampal atrophy (MTLE with presumed MTS), (b) lesions (LRTLE), and (c) normal anatomy (CTLE). Noninvasive tests are then applied to search for either concordance to an anatomic abnormality or a well-delineated temporal lobe EEG localization when the MRI is normal. For example, in a patient with a history of febrile seizures or early injury at age <4 years and unilateral hippocampal atrophy, a selective medial temporal resection might be indicated if the MTLE syndrome was confirmed by video-EEG–recorded appropriate ictal pattern, temporal lobe–specific short-term memory deficit, and unilateral hypometabolic PET scan when available. Finally, although the method and interpretation vary considerably, the intracarotid Amytal procedure (IAP) will usually demonstrate a more specific memory deficit in the suspicious temporal lobe.

A patient with a temporal lobe lesion also requires EEG concordance. Neuropsychological, PET, and IAP testing can range considerably from normal to various degrees of abnormality. These latter three tests are not well categorized regarding usefulness in deciding about a resection or its volume. Nonetheless, the concordance of scalp EEG and anatomic substrate directs the surgeon to a specific region. The variability of other tests can result from lesion location, extent and age of an injury or lesion, and the central nervous system response to the same. The IAP’s major role has been to assure the physician that memory is adequate in the temporal lobe opposite to the one to be surgically addressed. Outcome studies with substantial numbers of patients are needed to clarify how cognitive testing, IAP, PET, and ictal and interictal SPECT can be used in modifying decisions based on the major criteria of MRI substrate and EEG localization.

In cases in the third category (CTLE), in which hippocampal atrophy or T2 signal change does not clearly predict MTS and the MRI appears normal, all EEG criteria must be typical of MTLE and the PET scan likewise positive for selective medial temporal resection to be performed in some centers. Patients in this group with a normal MRI often undergo chronic invasive electrophysiologic recording of seizures. Almost all centers agree that some form of invasive recording must be used if the preoperative evaluation criteria are discordant with one another; particularly when any imaging abnormality (MRI, PET, or SPECT) conflicts with the EEG. The temporal lobe resection region will then be tailored to the invasive ictal findings.

Chronic invasive electrophysiologic monitoring shows that the majority of ictal events observed in TLE originate in the medial temporal lobe, often within the hippocampus.78,79,82,83 Electrographic ictal localization with invasive studies, such as depth and subdural electrodes, is accepted as the most accurate method for identifying the region of seizure onset.14,23,79 Use of interictal spikes was advocated historically and is still advocated by some to define the cortical resection.55 However, the location of interictal spikes has only been weakly correlated with the site of ictal onset or any pathology within the resected tissue.23,72

Considering that interictal spikes may represent synaptically mediated events propagated from distant abnormal sites, this finding is not unexpected.103 Epileptiform spiking can be nonspecific because it has been described in nonepileptic individuals.8 Ictal electrophysiologic data remain the standard for resective procedures for TLE. The disconnection of afferent and efferent networks also helps to explain how varied temporal lobectomy approaches across the spectrum from standardized to tailored resections can have similar outcome efficacy.

Discordant electrophysiology and imaging also may be seen in patients with LRTLE and may lead to invasive recordings to clarify ictal onset. When an MRI lesion is present, the necessity for invasive EEG is substrate dependent. It is infrequently necessary when the lesion is a neoplasm, circumscribed DA, or CA, unless there is ictal scalp onset clearly from another lobe or the opposite hemisphere. Other MRI lesions may not be associated so robustly with just perilesional epileptogenicity because a microscopic substrate may extend beyond the imaged abnormality. These patients with LRTLE require invasive recording to define the necessary and sufficient temporal lobe volume that must be removed. Common lesions in this category are most of the DAs, such as cortical dysplasia and gyration defects, and the indeterminate substrates, including traumatic and infectious gliosis and neuronal loss. Separate consideration for invasive monitoring may be necessary to stimulate and localize certain essential cortical regions such as language and sensorimotor areas when awake craniotomies are not possible, such as in children or adults with limited ability to undergo awake procedures.23


Goals of Surgery

In MTLE that meets evaluation criteria, neuropathologic, neuroanatomic, and neurophysiologic10,33,102 findings all identify abnormalities in the medial temporal structures, particularly
the hippocampus. Therefore, an extensive medial resection removes the majority of this epileptogenic substrate. Accumulated evidence suggests that the medial structures should be resected extensively in this syndrome. Depth electrodes placed parallel and through the long axis of the hippocampus have shown that electrical abnormalities are usually found throughout the body of the hippocampus, and less often is there a distinct segment of the hippocampus that initiates the seizure. In approximately 20% of patients with unilateral TLE studied with depth electrodes, abnormal electrical foci in the posterior portions of the hippocampus were not routinely resected by traditional standard lobectomies.78,83 MRI most frequently shows atrophy of the entire hippocampus.44 And although investigators have described a decreasing gradient of neuronal cell loss from anterior to posterior hippocampus, pathology is generally seen throughout.4 The need to include the posterior portions of the hippocampus in the medial resection was addressed by designing a more radical hippocampus and parahippocampectomy that preserved the lateral temporal cortex—the anterior medial temporal resection (AMTR). Finally, Wyler et al. reported a prospective, randomized study of patients undergoing surgery for MTLE, with ictal onset verified in each case by subdural recordings.105 They compared the AMTR to a more limited medial resection in this group. Complete seizure control was seen in 69% of the AMTR patients and in only 38% of the patients with a partial hippocampectomy. Other surgical options are also reviewed in what follows, representing variations of opinion of the extent of medial resection necessary and sufficient for success, and representing different approaches to minimizing the functional disruption of overlying cortex. They all share the common goal of medial temporal resection, specifically of the hippocampus.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 1, 2016 | Posted by in NEUROLOGY | Comments Off on Anterior Temporal Resection

Full access? Get Clinical Tree

Get Clinical Tree app for offline access